首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence
【2h】

Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence

机译:肺炎克雷伯菌AcrAB外排泵有助于抗菌素耐药性和毒力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Respiratory infections caused by Klebsiella pneumoniae are characterized by high rates of mortality and morbidity. Management of these infections is often difficult, due to the high frequency of strains that are resistant to multiple antimicrobial agents. Multidrug efflux pumps play a major role as a mechanism of antimicrobial resistance in Gram-negative pathogens. In the present study, we investigated the role of the K. pneumoniae AcrRAB operon in antimicrobial resistance and virulence by using isogenic knockouts deficient in the AcrB component and the AcrR repressor, both derived from the virulent strain 52145R. We demonstrated that the AcrB knockout was more susceptible, not only to quinolones, but also to other antimicrobial agents, including β-lactams, than the wild-type strain and the AcrR knockout. We further showed that the AcrB knockout was more susceptible to antimicrobial agents present in human bronchoalveolar lavage fluid and to human antimicrobial peptides than the wild-type strain and the AcrR knockout. Finally, the AcrB knockout exhibited a reduced capacity to cause pneumonia in a murine model, in contrast to the wild-type strain. The results of this study suggest that, in addition to contributing to the multidrug resistance phenotype, the AcrAB efflux pump may represent a novel virulence factor required for K. pneumoniae to resist innate immune defense mechanisms of the lung, thus facilitating the onset of pneumonia.
机译:由肺炎克雷伯菌引起的呼吸道感染的特征是死亡率和发病率很高。由于对多种抗菌剂具有耐药性的菌株的频率很高,因此通常难以管理这些感染。多药外排泵在革兰氏阴性病原体中起着重要的抗菌作用。在本研究中,我们通过使用均来自强毒株52145R的AcrB组分和AcrR阻遏物缺陷的基因敲除物,调查了肺炎克雷伯菌AcrRAB操纵子在抗菌素耐药性和毒力中的作用。我们证明,与野生型菌株和AcrR敲除相比,AcrB敲除不仅对喹诺酮类而且对其他抗菌剂(包括β-内酰胺类)更敏感。我们进一步表明,与野生型菌株和AcrR敲除相比,AcrB敲除对人类支气管肺泡灌洗液中存在的抗菌剂和人类抗菌肽更敏感。最后,与野生型菌株相比,AcrB基因敲除小鼠模型中引起肺炎的能力降低。这项研究的结果表明,除了促成多药耐药表型,AcrAB外排泵可能代表了肺炎克雷伯菌抵抗肺固有免疫防御机制所需的新型毒力因子,从而促进了肺炎的发作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号